Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis.

Authors:
Bouzek DC; Ren CL; Thompson M; Slaven JE; Sanders DB.

Journal:
Pediatr Pulmonol

Publication Year: 2022

DOI:
10.1002/ppul.25925

PMCID:
PMC9321873

PMID:
35429154

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pediatr Pulmonol

Abbreviation: Pediatr Pulmonol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A positive effect of a short period stay in Alpine environment on lung function in asthmatic childr…
Cogo A; Piazza M; Costella S and 6 more (2022) - Transparency Score: 3/6
A successful treatment of a lobar atelectasis in a patient with cystic fibrosis.
Daccò V; Sciarrabba CS; Corti F and 4 more (2022) - Transparency Score: 2/6
A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modu…
Kramer-Golinkoff E; Camacho A; Kramer L and 1 more (2022) - Transparency Score: 3/6
At-home end-tidal carbon dioxide measurement in children with invasive home mechanical ventilation.
Foster CC; Kwon S; Shah AV and 8 more (2022) - Transparency Score: 3/6
Collaborative decision-making: A framework for decision-making about life-sustaining treatments in …
Nageswaran S; Gower WA; Golden SL and 1 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST The authors declare no conflicts of interest."

Evidence found in paper:

"The authors would like to thank the patients, care providers, and care coordinators at the Riley Hospital for Children CF center for their contributions. This study was supported by the Cystic Fibrosis Foundation (Grant No. SANDER18Y7)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025